This review summarizes the pathogenesis of pulmonary arterial hypertension, emphasizing the roles of vascular remodeling, cellular heterogeneity, and key molecular mediators in disease progression and targeted therapy.
No takes yet. Share an insight, caveat, or question.
Affirms targeted therapies in PAH; leaves open optimal combinations and novel pathway exploration.
Perros et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: